TY - JOUR AU - Collaborators, G. H. PY - 2018 DA - 2018// TI - Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the global burden of disease study 2016 JO - Lancet Neurol VL - 17 UR - https://doi.org/10.1016/S1474-4422(18)30322-3 DO - 10.1016/S1474-4422(18)30322-3 ID - Collaborators2018 ER - TY - JOUR AU - Dabilgou, A. A. AU - Dravé, A. AU - Kyelem, J. M. A. AU - Sawadogo, Y. AU - Napon, C. AU - Millogo, A. PY - 2020 DA - 2020// TI - Frequency of headache disorders in neurology outpatients at Yalgado Ouedraogo University teaching hospital. A 3-month prospective cross-sectional study JO - SN Comprehensive Clinical Medicine VL - 2 UR - https://doi.org/10.1007/s42399-020-00238-8 DO - 10.1007/s42399-020-00238-8 ID - Dabilgou2020 ER - TY - JOUR PY - 2018 DA - 2018// TI - The International Classification of Headache Disorders, 3rd edition JO - Cephalalgia VL - 38 UR - https://doi.org/10.1177/0333102417738202 DO - 10.1177/0333102417738202 ID - ref3 ER - TY - STD TI - Chalmer MA, Hansen T, Lebedeva ER, Dodick DW, Lipton RB, Olesen J (2020) Proposed new diagnosticcriteria for chronic migraine. Cephalalgia 40(4):399-406 ID - ref4 ER - TY - JOUR AU - Natoli, J. L. AU - Manack, A. AU - Dean, B. AU - Butler, Q. AU - Turkel, C. C. AU - Stovner, L. PY - 2010 DA - 2010// TI - Global prevalence of chronic migraine: a systematic review JO - Cephalalgia VL - 30 UR - https://doi.org/10.1111/j.1468-2982.2009.01941.x DO - 10.1111/j.1468-2982.2009.01941.x ID - Natoli2010 ER - TY - JOUR AU - Manack, A. N. AU - Buse, D. C. AU - Lipton, R. B. PY - 2011 DA - 2011// TI - Chronic migraine: epidemiology and disease burden JO - Curr Pain Headache Rep VL - 15 UR - https://doi.org/10.1007/s11916-010-0157-z DO - 10.1007/s11916-010-0157-z ID - Manack2011 ER - TY - JOUR AU - Teixeira, A. L. AU - Costa, E. A. AU - Silva, A. A. AU - Santos, I. A. AU - Gómez, R. S. AU - Kummer, A. PY - 2012 DA - 2012// TI - Psychiatric comorbidities of chronic migraine in community and tertiary care clinic samples JO - J Headache Pain VL - 13 UR - https://doi.org/10.1007/s10194-012-0480-3 DO - 10.1007/s10194-012-0480-3 ID - Teixeira2012 ER - TY - JOUR AU - Aurora, S. K. AU - Dodick, D. W. AU - Turkel, C. C. AU - DeGryse, R. E. AU - Silberstein, S. D. AU - Lipton, R. B. PY - 2010 DA - 2010// TI - OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial JO - Cephalalgia. VL - 30 UR - https://doi.org/10.1177/0333102410364676 DO - 10.1177/0333102410364676 ID - Aurora2010 ER - TY - JOUR AU - Diener, H. C. AU - Dodick, D. W. AU - Aurora, S. K. AU - Turkel, C. C. AU - DeGryse, R. E. AU - Lipton, R. B. PY - 2010 DA - 2010// TI - OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial JO - Cephalalgia. VL - 30 UR - https://doi.org/10.1177/0333102410364677 DO - 10.1177/0333102410364677 ID - Diener2010 ER - TY - JOUR AU - Dodick, D. W. AU - Turkel, C. C. AU - DeGryse, R. E. AU - Aurora, S. K. AU - Silberstein, S. D. AU - Lipton, R. B. PY - 2010 DA - 2010// TI - OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program JO - Headache VL - 50 UR - https://doi.org/10.1111/j.1526-4610.2010.01678.x DO - 10.1111/j.1526-4610.2010.01678.x ID - Dodick2010 ER - TY - JOUR AU - Aurora, S. K. AU - Winner, P. AU - Freeman, M. C. AU - Spierings, E. L. AU - Heiring, J. O. AU - DeGryse, R. E. PY - 2011 DA - 2011// TI - OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program JO - Headache VL - 51 UR - https://doi.org/10.1111/j.1526-4610.2011.01990.x DO - 10.1111/j.1526-4610.2011.01990.x ID - Aurora2011 ER - TY - JOUR AU - Aurora, S. K. AU - Dodick, D. W. AU - Diener, H. C. AU - DeGryse, R. E. AU - Turkel, C. C. AU - Lipton, R. B. PY - 2014 DA - 2014// TI - OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program JO - Acta Neurol Scand VL - 129 UR - https://doi.org/10.1111/ane.12171 DO - 10.1111/ane.12171 ID - Aurora2014 ER - TY - JOUR AU - Khalil, M. AU - Zafar, H. W. AU - Quarshie, V. AU - Ahmed, F. PY - 2014 DA - 2014// TI - Prospective analysis of the use of OnabotulinumtoxinA (BOTOX) in the treatment of chronic migraine; real-life data in 254 patients from Hull, U.K JO - J Headache Pain VL - 15 UR - https://doi.org/10.1186/1129-2377-15-54 DO - 10.1186/1129-2377-15-54 ID - Khalil2014 ER - TY - JOUR AU - Cernuda-Morollón, E. AU - Ramón, C. AU - Larrosa, D. AU - Alvarez, R. AU - Riesco, N. AU - Pascual, J. PY - 2015 DA - 2015// TI - Long-term experience with onabotulinumtoxinA in the treatment of chronic migraine: what happens after one year? JO - Cephalalgia VL - 35 UR - https://doi.org/10.1177/0333102414561873 DO - 10.1177/0333102414561873 ID - Cernuda-Morollón2015 ER - TY - JOUR AU - Pedraza, M. I. AU - Cruz, C. AU - Ruiz, M. AU - López-Mesonero, L. AU - Martínez, E. AU - Lera, M. PY - 2015 DA - 2015// TI - OnabotulinumtoxinA treatment for chronic migraine: experience in 52 patients treated with the PREEMPT paradigm JO - Springerplus. VL - 4 UR - https://doi.org/10.1186/s40064-015-0957-z DO - 10.1186/s40064-015-0957-z ID - Pedraza2015 ER - TY - JOUR AU - Russo, M. AU - Manzoni, G. C. AU - Taga, A. AU - Genovese, A. AU - Veronesi, L. AU - Pasquarella, C. PY - 2016 DA - 2016// TI - The use of onabotulinum toxin a (Botox(®)) in the treatment of chronic migraine at the Parma headache Centre: a prospective observational study JO - Neurol Sci VL - 37 UR - https://doi.org/10.1007/s10072-016-2568-z DO - 10.1007/s10072-016-2568-z ID - Russo2016 ER - TY - JOUR AU - Aicua-Rapun, I. AU - Martínez-Velasco, E. AU - Rojo, A. AU - Hernando, A. AU - Ruiz, M. AU - Carreres, A. PY - 2016 DA - 2016// TI - Real-life data in 115 chronic migraine patients treated with Onabotulinumtoxin A during more than one year JO - J Headache Pain VL - 17 UR - https://doi.org/10.1186/s10194-016-0702-1 DO - 10.1186/s10194-016-0702-1 ID - Aicua-Rapun2016 ER - TY - JOUR AU - Kollewe, K. AU - Escher, C. M. AU - Wulff, D. U. AU - Fathi, D. AU - Paracka, L. AU - Mohammadi, B. PY - 2016 DA - 2016// TI - Long-term treatment of chronic migraine with OnabotulinumtoxinA: efficacy, quality of life and tolerability in a real-life setting JO - J Neural Transm (Vienna) VL - 123 UR - https://doi.org/10.1007/s00702-016-1539-0 DO - 10.1007/s00702-016-1539-0 ID - Kollewe2016 ER - TY - JOUR AU - Blumenfeld, A. M. AU - Stark, R. J. AU - Freeman, M. C. AU - Orejudos, A. AU - Manack, A. A. PY - 2018 DA - 2018// TI - Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study JO - J Headache Pain VL - 19 UR - https://doi.org/10.1186/s10194-018-0840-8 DO - 10.1186/s10194-018-0840-8 ID - Blumenfeld2018 ER - TY - JOUR AU - Ahmed, F. AU - Gaul, C. AU - García-Moncó, J. C. AU - Sommer, K. AU - Martelletti, P. AU - Investigators, R. P. PY - 2019 DA - 2019// TI - An open-label prospective study of the real-life use of onabotulinumtoxinA for the treatment of chronic migraine: the REPOSE study JO - J Headache Pain VL - 20 UR - https://doi.org/10.1186/s10194-019-0976-1 DO - 10.1186/s10194-019-0976-1 ID - Ahmed2019 ER - TY - JOUR AU - Stark, C. AU - Stark, R. AU - Limberg, N. AU - Rodrigues, J. AU - Cordato, D. AU - Schwartz, R. PY - 2019 DA - 2019// TI - Real-world effectiveness of onabotulinumtoxinA treatment for the prevention of headaches in adults with chronic migraine in Australia: a retrospective study JO - J Headache Pain VL - 20 UR - https://doi.org/10.1186/s10194-019-1030-z DO - 10.1186/s10194-019-1030-z ID - Stark2019 ER - TY - STD TI - Alpuente A, Gallardo VJ, Torres-Ferrus M, Alvarez-Sabin J, Pozo-Rosich P (2019) Early efficacy and late gain in chronic and high-frequency episodic migraine with onabotulinumtoxinA. Eur J Neurol. https://doi.org/10.1111/ene.14028 ID - ref22 ER - TY - JOUR AU - Eross, E. J. AU - Gladstone, J. P. AU - Lewis, S. AU - Rogers, R. AU - Dodick, D. W. PY - 2005 DA - 2005// TI - Duration of migraine is a predictor for response to botulinum toxin type a JO - Headache. VL - 45 UR - https://doi.org/10.1111/j.1526-4610.2005.05067.x DO - 10.1111/j.1526-4610.2005.05067.x ID - Eross2005 ER - TY - JOUR AU - Jakubowski, M. AU - McAllister, P. J. AU - Bajwa, Z. H. AU - Ward, T. N. AU - Smith, P. AU - Burstein, R. PY - 2006 DA - 2006// TI - Exploding vs. imploding headache in migraine prophylaxis with Botulinum Toxin A JO - Pain VL - 125 UR - https://doi.org/10.1016/j.pain.2006.09.012 DO - 10.1016/j.pain.2006.09.012 ID - Jakubowski2006 ER - TY - JOUR AU - Mathew, N. T. AU - Kailasam, J. AU - Meadors, L. PY - 2008 DA - 2008// TI - Predictors of response to botulinum toxin type a (BoNTA) in chronic daily headache JO - Headache. VL - 48 ID - Mathew2008 ER - TY - JOUR AU - Burstein, R. AU - Dodick, D. AU - Silberstein, S. PY - 2009 DA - 2009// TI - Migraine prophylaxis with botulinum toxin a is associated with perception of headache JO - Toxicon VL - 54 UR - https://doi.org/10.1016/j.toxicon.2009.01.009 DO - 10.1016/j.toxicon.2009.01.009 ID - Burstein2009 ER - TY - JOUR AU - Kim, C. C. AU - Bogart, M. M. AU - Wee, S. A. AU - Burstein, R. AU - Arndt, K. A. AU - Dover, J. S. PY - 2010 DA - 2010// TI - Predicting migraine responsiveness to botulinum toxin type a injections JO - Arch Dermatol VL - 146 UR - https://doi.org/10.1001/archdermatol.2009.356 DO - 10.1001/archdermatol.2009.356 ID - Kim2010 ER - TY - JOUR AU - Bumb, A. AU - Seifert, B. AU - Wetzel, S. AU - Agosti, R. PY - 2013 DA - 2013// TI - Patients profiling for Botox® (onabotulinum toxin a) treatment for migraine: a look at white matter lesions in the MRI as a potential marker JO - Springerplus. VL - 2 UR - https://doi.org/10.1186/2193-1801-2-377 DO - 10.1186/2193-1801-2-377 ID - Bumb2013 ER - TY - JOUR AU - Lin, K. H. AU - Chen, S. P. AU - Fuh, J. L. AU - Wang, Y. F. AU - Wang, S. J. PY - 2014 DA - 2014// TI - Efficacy, safety, and predictors of response to botulinum toxin type a in refractory chronic migraine: a retrospective study JO - J Chin Med Assoc VL - 77 UR - https://doi.org/10.1016/j.jcma.2013.09.006 DO - 10.1016/j.jcma.2013.09.006 ID - Lin2014 ER - TY - JOUR AU - Lee, M. J. AU - Lee, C. AU - Choi, H. AU - Chung, C. S. PY - 2016 DA - 2016// TI - Factors associated with favorable outcome in botulinum toxin a treatment for chronic migraine: a clinic-based prospective study JO - J Neurol Sci VL - 363 UR - https://doi.org/10.1016/j.jns.2016.01.054 DO - 10.1016/j.jns.2016.01.054 ID - Lee2016 ER - TY - JOUR AU - Domínguez, C. AU - Vieites-Prado, A. AU - Pérez-Mato, M. AU - Sobrino, T. AU - Rodríguez-Osorio, X. AU - López, A. PY - 2018 DA - 2018// TI - CGRP and PTX3 as predictors of efficacy of Onabotulinumtoxin type a in chronic migraine: an observational study JO - Headache. VL - 58 UR - https://doi.org/10.1111/head.13211 DO - 10.1111/head.13211 ID - Domínguez2018 ER - TY - JOUR AU - Domínguez, C. AU - Pozo-Rosich, P. AU - Leira, Y. AU - Leira, R. PY - 2018 DA - 2018// TI - Unilateral pain and shorter duration of chronic migraine are significant predictors of response to onabotulinumtoxin A JO - Eur J Neurol VL - 25 UR - https://doi.org/10.1111/ene.13570 DO - 10.1111/ene.13570 ID - Domínguez2018 ER - TY - JOUR AU - Schiano di Cola, F. AU - Caratozzolo, S. AU - Liberini, P. AU - Rao, R. AU - Padovani, A. PY - 2019 DA - 2019// TI - Response Predictors in Chronic Migraine: Medication Overuse and Depressive Symptoms Negatively Impact Onabotulinumtoxin-A Treatment JO - Front Neurol VL - 10 UR - https://doi.org/10.3389/fneur.2019.00678 DO - 10.3389/fneur.2019.00678 ID - Schiano di Cola2019 ER - TY - JOUR AU - Sacco, S. AU - Bendtsen, L. AU - Ashina, M. AU - Reuter, U. AU - Terwindt, G. AU - Mitsikostas, D. D. PY - 2019 DA - 2019// TI - European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention JO - J Headache Pain VL - 20 UR - https://doi.org/10.1186/s10194-018-0955-y DO - 10.1186/s10194-018-0955-y ID - Sacco2019 ER - TY - JOUR AU - Tiseo, C. AU - Ornello, R. AU - Pistoia, F. AU - Sacco, S. PY - 2019 DA - 2019// TI - How to integrate monoclonal antibodies targeting the calcitonin gene-related peptide or its receptor in daily clinical practice JO - J Headache Pain VL - 20 UR - https://doi.org/10.1186/s10194-019-1000-5 DO - 10.1186/s10194-019-1000-5 ID - Tiseo2019 ER - TY - JOUR AU - Olesen, J. AU - Steiner, T. J. PY - 2004 DA - 2004// TI - The international classification of headache disorders, 2nd edn (ICDH-II) JO - J Neurol Neurosurg Psychiatry VL - 75 UR - https://doi.org/10.1136/jnnp.2003.031286 DO - 10.1136/jnnp.2003.031286 ID - Olesen2004 ER - TY - JOUR PY - 2013 DA - 2013// TI - The International Classification of Headache Disorders, 3rd edition (beta version) JO - Cephalalgia VL - 33 UR - https://doi.org/10.1177/0333102413485658 DO - 10.1177/0333102413485658 ID - ref37 ER - TY - BOOK PY - 2012 DA - 2012// TI - Botulinum toxin type A for the prevention of headaches in adults with chronic migraine ID - ref38 ER - TY - JOUR AU - Bendtsen, L. AU - Sacco, S. AU - Ashina, M. AU - Mitsikostas, D. AU - Ahmed, F. AU - Pozo-Rosich, P. PY - 2018 DA - 2018// TI - Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation JO - J Headache Pain VL - 19 UR - https://doi.org/10.1186/s10194-018-0921-8 DO - 10.1186/s10194-018-0921-8 ID - Bendtsen2018 ER - TY - JOUR AU - Ahmed, F. AU - Zafar, H. W. AU - Buture, A. AU - Khalil, M. PY - 2015 DA - 2015// TI - Does analgesic overuse matter? Response to OnabotulinumtoxinA in patients with chronic migraine with or without medication overuse JO - Springerplus VL - 4 UR - https://doi.org/10.1186/s40064-015-1386-8 DO - 10.1186/s40064-015-1386-8 ID - Ahmed2015 ER - TY - JOUR AU - Herd, C. P. AU - Tomlinson, C. L. AU - Rick, C. AU - Scotton, W. J. AU - Edwards, J. AU - Ives, N. J. PY - 2019 DA - 2019// TI - Cochrane systematic review and meta-analysis of botulinum toxin for the prevention of migraine JO - BMJ Open VL - 9 UR - https://doi.org/10.1136/bmjopen-2018-027953 DO - 10.1136/bmjopen-2018-027953 ID - Herd2019 ER - TY - JOUR AU - Pijpers, J. A. AU - Kies, D. A. AU - Louter, M. A. AU - Zwet, E. W. AU - Ferrari, M. D. AU - Terwindt, G. M. PY - 2019 DA - 2019// TI - Acute withdrawal and botulinum toxin a in chronic migraine with medication overuse: a double-blind randomized controlled trial JO - Brain VL - 142 UR - https://doi.org/10.1093/brain/awz052 DO - 10.1093/brain/awz052 ID - Pijpers2019 ER - TY - JOUR AU - Dresler, T. AU - Caratozzolo, S. AU - Guldolf, K. AU - Huhn, J. I. AU - Loiacono, C. AU - Niiberg-Pikksööt, T. PY - 2019 DA - 2019// TI - Understanding the nature of psychiatric comorbidity in migraine: a systematic review focused on interactions and treatment implications JO - J Headache Pain VL - 20 UR - https://doi.org/10.1186/s10194-019-0988-x DO - 10.1186/s10194-019-0988-x ID - Dresler2019 ER - TY - JOUR AU - Pistoia, F. AU - Sacco, S. AU - Carolei, A. PY - 2013 DA - 2013// TI - Behavioral therapy for chronic migraine JO - Curr Pain Headache Rep VL - 17 UR - https://doi.org/10.1007/s11916-012-0304-9 DO - 10.1007/s11916-012-0304-9 ID - Pistoia2013 ER -